Suppr超能文献

[中药及天然化合物靶向自噬调控动脉粥样硬化的研究进展]

[Research progress in targeting autophagy of traditional Chinese medicine and natural compounds to regulate atherosclerosis].

作者信息

Zhou Man-Li, Yu Yun-Feng, Zhao Yan-Zhen, Luo Xiao-Xin, Zhu Jia-le, Hu Yi-Lei, Jian Wei-Xiong

机构信息

School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China.

School of Traditional Chinese Medicine, Hunan University of Chinese Medicine Changsha 410208, China Hunan Provincial Key Laboratory of National Key Discipline of Traditional Chinese Medicine Diagnostics,Hunan University of Chinese Medicine Changsha 410208, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2023 Jan;48(2):311-320. doi: 10.19540/j.cnki.cjcmm.20220726.405.

Abstract

Atherosclerosis(AS) is the common pathological basis of many ischemic cardiovascular diseases, and its formation process involves various aspects such as vascular endothelial injury and platelet activation. Vascular endothelial injury is the initiating factor of AS plaque. Monocytes are recruited to differentiate into macrophages at the damaged endothelial cells, which absorb oxidized low-density lipoprotein(ox-LDL) and slowly transform into foam cells. Smooth muscle cells(SMCs) proliferate and migrate continuously. As the only cell producing interstitial collagen fibers in the fibrous cap, SMCs largely determine whether the plaque ruptured or not. The amplifying inflammatory response during the formation of AS recruits platelets to adhere to the damaged area of vascular endothelium and stimulates excessive platelet aggregation. Autophagy activity is associated with vascular lesions and abnormal platelet activation, and excessive autophagy is considered to be a negative factor for plaque stability. Therefore, precise regulation of different types of vascular autophagy and platelet autophagy to treat AS may provide a new therapeutic perspective for the prevention and treatment of atherosclerotic ischemic cardiovascular disease. Currently, treatment strategies for AS still focus on lowering lipid levels with high-intensity statins, which often cause significant side effects. Therefore, the development of safer and more effective drugs and treatment modes is the focus of current research. Traditional Chinese medicine and natural compounds have the potential to treat AS by targeted autophagy, and have been playing an increasingly important role in the prevention and treatment of cardiovascular diseases in China. This paper summarizes the experimental studies on different vascular cell types and platelet autophagy in AS, and sums up the published research results on targeted autophagy of traditional Chinese medicine and natural plant compounds to regulate AS, providing new ideas for further research.

摘要

动脉粥样硬化(AS)是许多缺血性心血管疾病的共同病理基础,其形成过程涉及血管内皮损伤和血小板活化等多个方面。血管内皮损伤是AS斑块的起始因素。单核细胞被募集到受损的内皮细胞处分化为巨噬细胞,巨噬细胞摄取氧化型低密度脂蛋白(ox-LDL)并逐渐转变为泡沫细胞。平滑肌细胞(SMC)持续增殖和迁移。作为纤维帽中唯一产生间质胶原纤维的细胞,SMC在很大程度上决定了斑块是否会破裂。AS形成过程中放大的炎症反应会募集血小板黏附于血管内皮损伤部位,并刺激血小板过度聚集。自噬活性与血管病变及异常的血小板活化相关,过度自噬被认为是斑块稳定性的负面因素。因此,精确调控不同类型的血管自噬和血小板自噬以治疗AS可能为动脉粥样硬化性缺血性心血管疾病的防治提供新的治疗思路。目前,AS的治疗策略仍集中于使用高强度他汀类药物降低血脂水平,而这往往会引发显著的副作用。因此,开发更安全、有效的药物和治疗模式是当前研究的重点。中药和天然化合物具有通过靶向自噬治疗AS的潜力,在中国心血管疾病的防治中发挥着越来越重要的作用。本文综述了AS中不同血管细胞类型和血小板自噬的实验研究,并总结了关于中药和天然植物化合物靶向自噬调控AS的已发表研究成果,为进一步研究提供新思路。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验